PMID- 21716678
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20110714
LR  - 20230502
IS  - 1741-4288 (Electronic)
IS  - 1741-427X (Print)
IS  - 1741-427X (Linking)
VI  - 2012
DP  - 2012
TI  - Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and 
      insulin resistance in type 2 diabetes mellitus rats.
PG  - 981896
LID - 10.1155/2012/981896 [doi]
LID - 981896
AB  - The present study investigates the encapsulated propolis on blood glycemic 
      control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus 
      (T2DM) rats. The animal characteristics and biological assays of body weight, 
      fasting blood glucose (FBG), fasting serum insulin (FINS), insulin act index 
      (IAI), triglycerides (TG), total cholesterol (TC), high-density lipoprotein 
      cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were 
      measured and euglycemic hyperinsulinemic glucose clamp technique were used to 
      determine these effects. Our findings show that oral administration of 
      encapsulated propolis can significantly inhibit the increasing of FBG and TG in 
      T2DM rats and can improve IAI and M value in euglycemic hyperinsulinemic clamp 
      experiment. There was no significant effects on body weight, TC, HDL-C, and LDL-C 
      in T2DM rats treated with encapsulated propolis. In conclusion, the results 
      indicate that encapsulated propolis can control blood glucose, modulate lipid 
      metabolism, and improve the insulin sensitivity in T2DM rats.
FAU - Li, Yajing
AU  - Li Y
AD  - College of Animal Science, Zhejiang University, No. 268 Kaixuan Road, Hangzhou 
      310029, China.
FAU - Chen, Minli
AU  - Chen M
FAU - Xuan, Hongzhuan
AU  - Xuan H
FAU - Hu, Fuliang
AU  - Hu F
LA  - eng
PT  - Journal Article
DEP - 20110612
PL  - United States
TA  - Evid Based Complement Alternat Med
JT  - Evidence-based complementary and alternative medicine : eCAM
JID - 101215021
PMC - PMC3118452
EDAT- 2011/07/01 06:00
MHDA- 2011/07/01 06:01
PMCR- 2011/06/12
CRDT- 2011/07/01 06:00
PHST- 2010/12/18 00:00 [received]
PHST- 2011/03/15 00:00 [revised]
PHST- 2011/04/13 00:00 [accepted]
PHST- 2011/07/01 06:00 [entrez]
PHST- 2011/07/01 06:00 [pubmed]
PHST- 2011/07/01 06:01 [medline]
PHST- 2011/06/12 00:00 [pmc-release]
AID - 10.1155/2012/981896 [doi]
PST - ppublish
SO  - Evid Based Complement Alternat Med. 2012;2012:981896. doi: 10.1155/2012/981896. 
      Epub 2011 Jun 12.